The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
1400W Is a Slow, Tight Binding, and Highly Selective Inhibitor of Inducible Nitric-oxide Synthase in Vitro and in Vivo
Open accessAbstract
N-(3-(Aminomethyl)benzyl)acetamidine (1400W) was a slow, tight binding inhibitor of human inducible nitric- oxide synthase (iNOS). The slow onset of inhibition by 1400W showed saturation kinetics with a maximal rate constant of 0.028 s-1 and a binding constant of 2.0 microM. Inhibition was dependent on the cofactor NADPH. L-Arginine was a competitive inhibitor of 1400W binding with a Ks value of 3.0 microM. Inhibited enzyme did not recover activity after 2 h. Thus, 1400W was either an irreversible inhibitor or an extremely slowly reversible inhibitor of human iNOS with a Kd value </= 7 nM. In contrast, inhibition of human neuronal NOS and endothelial NOS (eNOS) was relatively weaker, rapidly reversible, and competitive with L-arginine, with Ki values of 2 microM and 50 microM, respectively. Thus, 1400W was at least 5000-fold selective for iNOS versus eNOS. This selectivity was similar to that observed in rat aortic rings, in which 1400W was greater than 1000-fold more potent against rat iNOS than eNOS. Finally, 1400W was greater than 50-fold more potent against iNOS than eNOS in a rat model of endotoxin-induced vascular injury. Thus, the potency and selectivity of 1400W inhibition of iNOS both in vitro and in vivo were far greater than of any previously described iNOS inhibitor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Nitric Oxide: Pathophysiological Mechanisms
Gross, S. S., & Wolin, M. S. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.003513 · Cited by 888
Rees, D. D., Palmer, R. M. J., Hodson, H. F., & Moncada, S. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb11833.x · Cited by 850
Rees, D. D., Cellek, S., Palmer, R. M. J., & Moncada, S. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80068-3 · Cited by 590
Baek, K. J., Thiel, B. A., Lucas, S., & Stuehr, D. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36901-7 · Cited by 389
Purification of a soluble isoform of guanylyl cyclase-activating-factor synthase.
Schmidt, H. H., Pollock, J. S., Nakane, M., Gorsky, L. D., Förstermann, U., & Murad, F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.2.365 · Cited by 381
Garvey, E. P., Oplinger, J. A., Tanoury, G. J., Sherman, P. A., Fowler, M., Marshall, S., Harmon, M. F., Paith, J. E., & Furfine, E. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47071-8 · Cited by 315
Self-citationSuppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase
Connor, J. R., Manning, P. T., Settle, S. L., Moore, W. M., Jerome, G. M., Webber, R. K., Tjoeng, F. S., & Currie, M. G. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)00672-t · Cited by 297
Selective inhibition of constitutive nitric oxide synthase by L-NG-nitroarginine
Furfine, E. S., Harmon, M. F., Paith, J. E., & Garvey, E. P. (1993) · Biochemistry · doi:10.1021/bi00084a017 · Cited by 279
Self-citationIsothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity
Southan, G. J., Szabó, C., & Thiemermann, C. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb13256.x · Cited by 278
McCall, T. B., Feelisch, M., Palmer, R. M. J., & Moncada, S. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb12159.x · Cited by 251
Furfine, E. S., Harmon, M. F., Paith, J. E., Knowles, R. G., Salter, M., Kiff, R. J., Duffy, C., Hazelwood, R., Oplinger, J. A., & Garvey, E. P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47072-x · Cited by 219
Self-citationAminoguanidine Is an Isoform-Selective, Mechanism-Based Inactivator of Nitric Oxide Synthase
Wolff, D. J., & Lubeskie, A. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1040 · Cited by 187
László, F. A., Whittle, B. J. R., & Moncada, S. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14887.x · Cited by 137
Self-citationLászló, F. A., Evans, S., & Whittle, B. J. R. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)00637-m · Cited by 131
Self-citationNovel potent and selective inhibitors of inducible nitric oxide synthase.
Nakane, M., Klinghofer, V., Kuk, J. E., et al. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08614-6 · Cited by 126
Inactivation of macrophage nitric oxide synthase activity by NG-Methyl-L-arginine
Olken, N. M., Rusche, K. M., Richards, M. K., & Marletta, M. A. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91864-9 · Cited by 112
Purification and Characterization of the Constitutive Nitric-Oxide Synthase from Human Placenta
Garvey, E. P., Tuttle, J. V., Covington, K., Merrill, B. M., Wood, E. R., Baylis, S. A., & Charles, I. G. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1232 · Cited by 102
Self-citationMoore, W. M., Webber, R. K., Fok, K. F., Jerome, G. M., Connor, J. R., Manning, P. T., Wyatt, P. S., Misko, T. P., Tjoeng, F. S., & Currie, M. G. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950766n · Cited by 88
Olken, N. M., Osawa, Y., & Marletta, M. A. (1994) · Biochemistry · doi:10.1021/bi00253a017 · Cited by 63
Or, E., David, P., Shainskaya, A., Tal, D. M., & KARLISH, S. J. D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85284-5 · Cited by 43
Laubach, V. E., Garvey, E. P., & Sherman, P. A. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0143 · Cited by 36
Self-citationPurification and inhibitor screening of human nitric oxide synthase isozymes
Garvey, E. P., Furfine, E. S., & Sherman, P. A. (1996) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(96)68036-7 · Cited by 14
Self-citation
Cited by
Nitric oxide synthases: structure, function and inhibition
ALDERTON, W. K., COOPER, C. E., & KNOWLES, R. G. (2001) · Biochemical Journal · doi:10.1042/bj3570593 · Cited by 4,110
Self-citationCysteine-Mediated Redox Signaling: Chemistry, Biology, and Tools for Discovery
Paulsen, C. E., & Carroll, K. S. (2013) · Chemical Reviews · doi:10.1021/cr300163e · Cited by 1,278
CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
Giavridis, T., van der Stegen, S. J. C., Eyquem, J., Hamieh, M., Piersigilli, A., & Sadelain, M. (2018) · Nature Medicine · doi:10.1038/s41591-018-0041-7 · Cited by 1,272
Klug, F., Prakash, H., Huber, P. E., Seibel, T., Bender, N., Halama, N., Pfirschke, C., Voss, R. H., Timke, C., Umansky, L., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.09.014 · Cited by 1,099
Mitochondrial dysfunction prevents repolarization of inflammatory macrophages
Van den Bossche, J., Baardman, J., Otto, N. A., van der Velden, S., Neele, A. E., van den Berg, S. M., Luque-Martin, R., Chen, H.-J., Boshuizen, M. C. S., Ahmed, M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.008 · Cited by 1,027
Metadata
- Authors
- Garvey, E. P., Oplinger, J. A., Furfine, E. S., Kiff, R. J., Laszlo, F., Whittle, B. J. R., & Knowles, R. G.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-02
- Volume
- 272
- Issue
- 8
- Pages
- 4959-4963
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2052391094
- Cited by
- 845
- References
- 23
- FWCI
- 19.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.